{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T15:20:50Z","timestamp":1772119250869,"version":"3.50.1"},"reference-count":18,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T00:00:00Z","timestamp":1760140800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T00:00:00Z","timestamp":1760140800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Hematol"],"DOI":"10.1007\/s00277-025-06645-y","type":"journal-article","created":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T04:47:58Z","timestamp":1760158078000},"page":"5323-5331","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Infection events in patients with newly diagnosed multiple myeloma with anti-CD38 monoclonal antibody-based first line regimens: A multicentric Italian experience"],"prefix":"10.1007","volume":"104","author":[{"given":"Angela","family":"Rago","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francesca","family":"Fioritoni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carmine","family":"Liberatore","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stefano","family":"Pulini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francesca","family":"Fazio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria Teresa","family":"Petrucci","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Valerio","family":"De Stefano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elena","family":"Rossi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tommaso","family":"Za","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francesca","family":"Di Landro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laura","family":"De Padua","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masssimo","family":"Offidani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sonia","family":"More","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Annibali","family":"Ombretta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Valeria","family":"Tomarchio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria Antonietta","family":"Tafuri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alfonso","family":"Piciocchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luca","family":"Franceschini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alessia","family":"Fiorini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tommaso Caravita","family":"di Toritto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,10,11]]},"reference":[{"key":"6645_CR1","doi-asserted-by":"publisher","first-page":"4519","DOI":"10.1182\/blood-2011-06-358812","volume":"118","author":"A Palumbo","year":"2011","unstructured":"Palumbo A, Bringhen S, Ludwig H, Dimopoulos MA, Blad\u00e9 J, Mateos MV, Rosi\u00f1ol L, Boccadoro M, Cavo M, Lokhorst H, Zweegman S, Terpos E, Davies F, Driessen C, Gimsing P, Gramatzki M, H\u00e0jek R, Johnsen HE, Leal Da Costa F, Sezer O, Spencer A, Beksac M, Morgan G, Einsele H, San Miguel JF, Sonneveld P (2011) Personalized therapy in multiple myeloma according to patient age and vulnerability: a report of the European myeloma network (EMN). Blood 118:4519\u20134529","journal-title":"Blood"},{"key":"6645_CR2","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1056\/NEJM199607113350204","volume":"11","author":"M Attal","year":"1996","unstructured":"Attal M, Harousseau JL, Stoppa AM, Sotto JJ, Fuzibet JG, Rossi JF, Casassus P, Maisonneuve H, Facon T, Ifrah N, Payen C, Bataille R (1996) A prospective, randomized trial of autologous bone marrow transplantation and chemotherapy in multiple myeloma. Intergroupe Fran\u00e7ais du My\u00e9lome. N Engl J Med 11:335:91\u201397","journal-title":"N Engl J Med"},{"key":"6645_CR3","doi-asserted-by":"crossref","unstructured":"Encinas C, Hernadez-Rivas JA, Oriol A B, Garc\u00eda-Sanz R6, De La Rubia J L\u00f3pez De La Gu\u00eda A, J\u00edmenez-Ubieto A, Jarque I, I\u00f1igo\u00a0B, Dourdil V, De Arriba F, Cu\u00e9llar P\u00e9rez-\u00c1vila C, Gonzalez Y, Hern\u00e1ndez TM, Bargay J, Granell M, Rodr\u00edguez-Otero P, Silvent M, Cabrera C, Rios R, Alegre A, Gironella M, Gonzalez MS, Sureda A, Sampol A,Ocio E M, Krsnik I, Garc\u00eda A, Garc\u00eda-Mateo A, Soler JA, Mart\u00edn J, Argui\u00f1ano JM, Mateos MV, Blad\u00e9 J, San-Miguel JF, Lahuerta JJ, Mart\u00ednez-L\u00f3pez J (2022) GEM\/PETHEMA (Grupo Espa\u00f1ol De Mieloma\/Programa Para El Estudio De La Terap\u00e9utica En Hemopat\u00edas Malignas) Coop Study Group Simple Score Predict Early Severe Infections Patients New Diagnosed Multiple Myeloma Blood Cancer 12:68","DOI":"10.1038\/s41408-022-00652-2"},{"key":"6645_CR4","doi-asserted-by":"publisher","first-page":"107","DOI":"10.3324\/haematol.2014.107714","volume":"100","author":"C Blimark","year":"2015","unstructured":"Blimark C, Holmberg E, Mellqvist U-H, Landgren O, Bj\u00f6rkholm M, Hultcrantz M, Kjellander C, Turesson Ingemar, Kristinsson Sigurdur Y (2015) Multiple myeloma and infections: a population-based study on 9253 multiple myeloma patients. Haematologica 100:107\u201313","journal-title":"Haematologica"},{"key":"6645_CR5","doi-asserted-by":"publisher","first-page":"1211","DOI":"10.1086\/605664","volume":"49","author":"M Nucci","year":"2009","unstructured":"Nucci M, Anaissie E (2009) Infections in patients with multiple myeloma in the era of high-dose therapy and novel agents. Clin Infect Dis 49:1211\u20131225","journal-title":"Clin Infect Dis"},{"key":"6645_CR6","doi-asserted-by":"crossref","unstructured":"Caro J, Braunstein M, Williams L, Bruno B, Kaminetzky D, Siegel A, Razzo B, Alfanari S, Gareth J, Morgan, Davies FE, Boyle EM (2022) Inflammation and infection in plasma cell disorders: how pathogens shape the fate of patients leukemia. 36:613\u2013624","DOI":"10.1038\/s41375-021-01506-9"},{"key":"6645_CR7","doi-asserted-by":"crossref","unstructured":"Facon T,\u00a0Kumar\u00a0SK, Plesner T, Orlowski RZ, Moreau P, Bahlis N, Basu S, Nahi H, Hulin C, Quach H, Goldschmidt H, O\u2019dwyer M, Perrot A, Venner CP, Weisel K, Mace JR, Raje N, Tiab M, Macro M, Frenzel F, Leleu X, Ahmadi T, Wang J, Rampelbergh RV, Uhlar CM,Tromp B, Delioukina M, Vermeulen J, Usmani SZ (2021) Daratumumab lenalidomide dexamethasone versus lenalidomide dexamethasone alone new diagnosed multiple myeloma (MAIA): Overall survival results randomised open-label phase 3 trial lancet oncol 22:1582\u20131596","DOI":"10.1016\/S1470-2045(21)00466-6"},{"key":"6645_CR8","doi-asserted-by":"crossref","unstructured":"Bahlis NJ, Dimopoulos MA, White DJ, Benboubker L, Cook G, Leiba M, Ho PJ, Kim K, Takezako N, Moreau P, Kaufman JL,Krevvata M, Chiu C, Qin X, Okonkwo L, Trivedi S, Ukropec J, Qi M, Miguel JS(2020)\u00a0Daratumumab Plus Lenalidomide Dexamethasone relapsed\/refractory Multiple Myeloma: Ext follow-up POLLUX Randomized open-label Phase 3. Study Leuk 34:1875\u20131884","DOI":"10.1038\/s41375-020-0711-6"},{"key":"6645_CR9","doi-asserted-by":"crossref","unstructured":"Vassilopoulos S, Vassilopoulos A, Kalligeros M, Shehadeh F, Mylonakis E (2022)\u00a0Cumulative incidence and relative risk of infection in patients with multiple myeloma treated with anti-cd38 monoclonal antibody-based regimens: a systematic review and meta-analysis. Open Forum Infect Dis 31;9(11)","DOI":"10.1093\/ofid\/ofac574"},{"key":"6645_CR10","doi-asserted-by":"crossref","unstructured":"Yanaba K, Yoshizaki A, Muroi E, Hara T, Ogawa F, Shimizu K, Sato S (2010) The proteasome inhibitor bortezomib inhibits T cell-dependent inflammatory responses. J Leukoc Biol Jul 88(1):117\u2013122","DOI":"10.1189\/jlb.1009666"},{"key":"6645_CR11","doi-asserted-by":"crossref","unstructured":"Quach H, Ritchie D, Stewart AK, Neeson P, Harrison S, Smyth MJ, Prince HM (2009) Mechanism of action of immunomodulatory drugs (IMiDS) in multiple myeloma Leukemia. 12;24:22\u201332","DOI":"10.1038\/leu.2009.236"},{"key":"6645_CR12","doi-asserted-by":"publisher","first-page":"846","DOI":"10.2174\/1568009617666170214104426","volume":"17","author":"S Raza","year":"2017","unstructured":"Raza S, Safyan RA, Lentzsch S (2017) Immunomodulatory drugs (IMiDs) in multiple myeloma. Curr Cancer Drug Target 17:846\u2013857","journal-title":"Curr Cancer Drug Target"},{"issue":"8","key":"6645_CR13","first-page":"765","volume":"30","author":"A Colley","year":"2024","unstructured":"Colley A, Brauns T, Sluder AE, Poznansky MC, Gemechu Y (2024) Immunomodulatory drugs: a promising clinical ally for cancer immunotherapy. Trends Molecl Medicine 30(8):765\u2013780","journal-title":"Immunomodulatory drugs: a promising clinical ally for cancer immunotherapy"},{"key":"6645_CR14","doi-asserted-by":"crossref","unstructured":"Li W, Liang L, Liao Q, Li Y, Zhou Y (2022) CD38: An important regulator of t cell function. Biomed Pharmacother 153:113395","DOI":"10.1016\/j.biopha.2022.113395"},{"issue":"6","key":"6645_CR15","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1038\/s41408-018-0077-4","volume":"12","author":"A Lakshman","year":"2018","unstructured":"Lakshman A, Rajkumar SV, Buadi FK, Binder M, Gertz MA, Lacy MQ, Dispenzieri A, Dingli D, Fonder AL, Hayman SR, Hobbs MA, Gonsalves WI, Hwa YL, Kapoor P, Leung N, Go RS, Lin Y, Kourelis TV, Warsame R, Lust JA, Russell SJ, Zeldenrust SR, Kyle RA, Kumar SK (2018) Risk stratification of smoldering multiple myeloma incorporating revised IMWG diagnostic criteria. Blood Cancer J 12(6):59","journal-title":"Blood Cancer J"},{"key":"6645_CR16","doi-asserted-by":"publisher","DOI":"10.1016\/j.jgo.2024.102051","volume":"15","author":"A Gahagan","year":"2024","unstructured":"Gahagan A, Maheshwari S, Rangarajan S, Ubersax C, Tucker A, Harmon C, Pasala MS, Bal S, Godby K, Ravi G, Costa LJ, Williams GR, Bhatia S, Giri SJ (2024) Evaluating concordance between international myeloma working group (IMWG) frailty score and simplified frailty scale among older adults with multiple myeloma. J Geriatr Oncol 15:102051","journal-title":"J Geriatr Oncol"},{"key":"6645_CR17","doi-asserted-by":"crossref","unstructured":"Lim C, Sinha P, Harrison SJ, Quach H, Slavin MA,\u00a0Teh BW (2021) Epidemiology and risks of infections in patients with multiple myeloma managed with new generation therapies. Clin Lymphoma Myeloma Leu 21:444\u2013450","DOI":"10.1016\/j.clml.2021.02.002"},{"key":"6645_CR18","unstructured":"World Health Organization \u2019s International Statistical Classification of Diseases\u201310th Revision (ICD-10)"}],"container-title":["Annals of Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-025-06645-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00277-025-06645-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-025-06645-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,15]],"date-time":"2025-11-15T08:19:06Z","timestamp":1763194746000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00277-025-06645-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,11]]},"references-count":18,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2025,10]]}},"alternative-id":["6645"],"URL":"https:\/\/doi.org\/10.1007\/s00277-025-06645-y","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-6779049\/v1","asserted-by":"object"}]},"ISSN":["1432-0584"],"issn-type":[{"value":"1432-0584","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,11]]},"assertion":[{"value":"29 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 September 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 October 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"statement andethical approval was obtained from a named committee (Comitato Etico Lazio 1) and that informed consent was received from all participants accordance with the Declaration of Helsinki.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}